[18F]‐Fluoro‐2‐deoxy‐D‐galactose positron emission tomography/computed tomography as complementary imaging tool in patients with hepatocellular carcinoma von Bak‐Fredslund, Kirstine P., Keiding, Susanne, Villadsen, Gerda E., Kramer, Stine, Schlander, Sven, Sørensen, Michael

Volltext

Prognostic modeling for patients with colorectal liver metastases incorporating FDG PET radiomic features von Rahmim, Arman, Bak-Fredslund, Kirstine P., Ashrafinia, Saeed, Lu, Lijun, Schmidtlein, C. Ross, Subramaniam, Rathan M., Morsing, Anni, Keiding, Susanne, Horsager, Jacob, Munk, Ole L.

Volltext

Metabolic liver function in humans measured by 2-18F-fluoro-2-deoxy-D-galactose PET/CT–reproducibility and clinical potential von Bak-Fredslund, Kirstine P., Lykke Eriksen, Peter, Munk, Ole L., Villadsen, Gerda E., Keiding, Susanne, Sørensen, Michael

Volltext

2-[18 F]fluoro-2-deoxy- D -galactose PET/CT of hepatocellular carcinoma is not improved by co-administration of galactose von Bak-Fredslund, Kirstine P, Munk, Ole Lajord, Keiding, Susanne, Sørensen, Michael

Volltext

Metabolic liver function in humans measured by 2- 18 F-fluoro-2-deoxy-D-galactose PET/CT-reproducibility and clinical potential von Bak-Fredslund, Kirstine P, Lykke Eriksen, Peter, Munk, Ole L, Villadsen, Gerda E, Keiding, Susanne, Sørensen, Michael

Volltext

Metabolic liver function in humans measured by 2-^sup 18^F-fluoro-2-deoxy-D-galactose PET/CT–reproducibility and clinical potential von Bak-fredslund, Kirstine P, Lykke Eriksen, Peter, Munk, Ole L, Villadsen, Gerda E, Keiding, Susanne, Sørensen, Michael

Volltext